Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Treasury Shares (2018 - 2025)

STRATA Skin Sciences' Treasury Shares history spans 7 years, with the latest figure at $851.0 for Q2 2024.

  • For Q2 2024, Treasury Shares fell 97.87% year-over-year to $851.0; the TTM value through Jun 2024 reached $851.0, down 97.87%, while the annual FY2023 figure was $2265.0, 81.06% down from the prior year.
  • Treasury Shares for Q2 2024 was $851.0 at STRATA Skin Sciences, down from $16991.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $179613.0 in Q3 2023 and bottomed at $851.0 in Q2 2024.
  • The 5-year median for Treasury Shares is $89681.0 (2022), against an average of $86618.7.
  • The largest annual shift saw Treasury Shares rose 21.09% in 2021 before it crashed 97.87% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $119330.0 in 2020, then decreased by 24.13% to $90540.0 in 2021, then tumbled by 86.79% to $11960.0 in 2022, then plummeted by 81.06% to $2265.0 in 2023, then crashed by 62.43% to $851.0 in 2024.
  • Per Business Quant, the three most recent readings for SSKN's Treasury Shares are $851.0 (Q2 2024), $16991.0 (Q1 2024), and $2265.0 (Q4 2023).